Beranda › Gangguan Somnolen Berlebih › Michigan
Uji klinis Gangguan Somnolen Berlebih di Michigan
7 studi untuk Gangguan Somnolen Berlebih mencari peserta di lokasi di Michigan.
Kota di Michigan
Teks studi resmi (Bahasa Inggris)
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
- Revive Research Institute, Southfield
- Clinical Neuropsychology Services, Sterling Heights
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07500090A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
- Alkermes Investigational Site, Lansing
- Alkermes Investigational Site, Novi
Menerima pesertaFase 3
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07455383A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
- Alkermes Investigational Site, Lansing
- Alkermes Investigational Site, Novi
Menerima pesertaFase 3
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07502443A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)
- Alkermes Investigational Site, Lansing
Menerima pesertaFase 3
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07540897A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
- Alkermes Investigational Site, Lansing
- Alkermes Investigational Site, Sterling Heights
Menerima pesertaFase 2/3
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT06767683Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)
- Clinical Research Site, Lansing
- Clinical Research Site, Novi
- Clinical Research Site, Southfield
Menerima pesertaFase 3
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 24 Jul 2026 · NCT06568367A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
- Sterling Heights, Michigan, Sterling Heights
Menerima pesertaFase 2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 16 Apr 2026 · NCT07096674Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.